April 30, 2020news
The GTFCC Steering Committee urges countries to continue reactive vaccination campaigns and to resume preventative immunization with Oral Cholera Vaccine (OCV) in cholera hotspots during the COVID-19 response as soon as it can be done safely.
The novel corona virus pandemic has caused a worldwide strain on health systems that is unprecedented in modern times. This is a global crisis that calls for solidarity among all peoples as the world seeks solutions at community, subnational, national, and global levels. As part of our collective efforts to minimize the loss of human life from COVID-19, we must work to maintain essential health services and systems – including immunization – wherever possible.
To this end, the World Health Organization (WHO) has issued a statement, endorsed by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), outlining Guiding principles for immunization activities during the COVID-19 pandemic. While the need for social distancing requires the temporary suspension of preventive mass vaccination campaigns, the WHO guidance calls for these lifesaving campaigns to be resumed as soon as possible. In resuming vaccination campaigns, countries must conduct careful risk assessments and apply appropriate protective measures to avoid transmission of the COVID-19. It is imperative that immunization services be maintained and resumed—particularly for epidemic-prone diseases like cholera—as a highest priority.
As an oral vaccine administered using a single-dose vial, OCV is well-suited for innovative delivery approaches. It does not require skilled personnel for administration and can be provided through directly observed no-contact self-administration, a known practice limiting contact between vaccinators and recipients.
The GTFCC Steering Committee strongly endorses these innovative delivery approaches. Both preventive and reactive cholera campaigns have now been suspended in several countries, resulting in a high risk of cholera outbreaks. Cholera is a deadly disease with high outbreak potential and a significant case fatality rate – up to five percent in the most vulnerable settings. A cholera outbreak causes severe strain on health systems and would severely compromise—and be compromised by—the COVID-19 response. It is therefore critical to avert cholera outbreaks through immunization, now more than ever.
To this end, in alignment with the guidance from WHO and SAGE, the GTFCC Steering Committee calls on countries and partner organizations to safely maintain reactive vaccination during cholera outbreaks and to reinstate cholera preventive vaccination campaigns as soon as possible. We call on health system leaders to:
Like cholera, COVID-19 is likely to affect the world’s poorest and most vulnerable communities most severely. Our best support to these communities during this crisis must include a strong primary health care system, including immunization against deadly diseases like cholera.
For more information follow the GTFCC Secretariat on Twitter @SecGTFCC